Winslow Evans & Crocker’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,100
Closed -$32K 1118
2020
Q2
$32K Buy
+1,100
New +$30.4K 0.01% 523

Other funds holding HCAT

Winslow Evans & Crocker's HCAT Position: Q3 2020 in Review

Winslow Evans & Crocker sold out of Health Catalyst (HCAT) in Q3 2020, closing a stake of 1,100 shares — an estimated $32K sold.

Winslow Evans & Crocker first reported a position in HCAT in Q2 2020 and held it in 1 quarter. The position peaked at $32K in Q2 2020. 138 funds tracked by Wall St. Rank hold HCAT as of Q3 2020.

  • Winslow Evans & Crocker reported no remaining Health Catalyst position as of Q3 2020 after selling out during the quarter.
  • Winslow Evans & Crocker sold 1,100 Health Catalyst shares in Q3 2020, an estimated $32K.
  • Winslow Evans & Crocker first reported a position in Health Catalyst in Q2 2020 and held it in 1 quarter.
  • Winslow Evans & Crocker's Health Catalyst position peaked at $32K in Q2 2020.
  • 138 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2020.

Based on Winslow Evans & Crocker's 13F filing for Q3 2020, filed 21 Oct 2020.